杨旭平，女。出生日期：1989年03月。四川大学华西临床医学院临床药学专业博士研究生，西南医科大学硕士研究生导师。四川省国际医学交流促进会合理用药分会常务委员，泸州市药学会委员，泸州市药学会临床药学专委会委员。近年来以第一或通讯作者在British Journal of Pharmacology、Phytomedicine、European Journal of Pharmacology等期刊上发表SCI论文7篇。主持国家自然科学基金、四川省医药协会及校级项目各1项，指导大创项目3项。
学院/部门：临床药学教研室，西南医科大学附属医院药学部
通讯方式：yangxuping6552@163.com
通讯地址：四川省泸州市龙马潭区西南医科大学弘润楼517
主要研究领域：
（1）胰岛素抵抗与能量稳态调节；
（2）口服降糖药的作用机制研究。
教育经历：
2007.09-2011.06 西南医科大学，药学专业，本科；
2011.09-2014.06 西南医科大学，药理学专业，硕士研究生；
2014.09-2019.06 四川大学，临床药学专业，博士研究生。
代表性论文：
(1) Wanlong Zhu, Ke Peng, Yan Zhao, Changjing Xu, Xuemei Tao, Yuanzhi Liu, Yilan Huang*, Xuping Yang*. Sodium butyrate attenuated diet-induced obesity, insulin resistance and inflammation partly by promoting fat thermogenesis via intro-adipose sympathetic innervation. Frontiers in Pharmacology. 2022,13:938760. (IF =5.988, JCR Q1)
(2) Wanlong Zhu, Liya Fu, Changjing Xu, Ke Peng，Yuanzhi Liu, Hui Tang, Yilan Huang*，Xuping Yang*. Enoxacin ameliorates polycystic ovary syndrome by promoting the browning of white adipose tissue. Frontiers in Pharmacology.2022. 13:978019 (IF =5.988, JCR Q1)
(3) Dongmei Tian#, Xiaoyan Zhong#, Liya Fu, Wanlong Zhu, Xin Liu, Zhigui Wu, Yue Li, Xue Li , Xuesen Li, Xuemei Tao, Qiming Wei, Xuping Yang*, Yilan Huang*.Therapeutic effect and mechanism of polysaccharides from Anoectochilus Roxburghii(Wall.) Lindl. in diet- induced obesity. Phytomedicine. 2022; 99: 154031. (IF= 6.656, JCR Q1)
(4) Liya Fu, Wanlong Zhu, Dongmei Tian, Yong Tang, Yun Ye , Qiming Wei, Chengbin Zhang, Wenqiao Qiu, Dalian Qin, Xuping Yang*, Yilan Huang*. Dietary Supplement of Anoectochilus roxburghii (Wall.) Lindl. Polysaccharides Ameliorates Cognitive Dysfunction Induced by High Fat Diet via “Gut-Brain” Axis. Drug Des Devel Ther. 2022;16:1931-1945. (IF =4.319, JCR Q2)
(5) Xuping Yang; Qinhui Liu; Yanping Li; Yi Ding; Yan Zhao; Qin Tang; Tong Wu; Lei Chen; Shiyun Pu; Shihai Cheng; Jinhang Zhang; Zijing Zhang; Ya Huang; Rui Li; Yingnan Zhao; Min Zou; Xiongjie Shi; Wei Jiang; Rui Wang*; Jinhan He*; SGLT2 Inhibition by Canagliflozin Ameliorates Diet-induced Obesity by Promoting Intraadipose Sympathetic Innervation , British Journal of Pharmacology, 2021, 178(8):1756-1771. (IF= 8.71, JCR Q1)
(6)Xuping Yang; Qinhui Liu; Yanping Li; Qin Tang; Tong Wu; Lei Chen; Shiyun Pu; Yingnan Zhao; Guorong Zhang; Cuiyuan Huang; Jinhang Zhang; Zijing Zhang; Ya Huang; Min Zou; Xiongjie Shi; Wei Jiang; Rui Wang*; Jinhan He*; The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway , Adipocyte, 2020, 9(1): 484-494. （IF=4.53, JCR Q2）
(7)Xuping Yang#; Dan Lai#; Xiaoyan Zhong; Hongping Shen; Yilan Huang*; Efficacy and safety of canagliflozin in subjects with type 2 diabetes: systematic review and meta-analysis , European Journal of Pharmacology, 2014, 17(10): 1149-1158. (IF=2.96, JCR Q2)
(8)Qin Tang; Qinhui Liu; Xuping Yang; Tong Wu; Cuiyuan Huang; Jinhang Zhang; Zijing Zhang; Guorong Zhang; Yingnan Zhao; Jian Zhou; Hui Huang; Yan Xia; Jiamin Yan; Yanping Li; Jinhan He*; Sirtuin 6 supra ‐ physiological overexpression in hypothalamic pro-opiomelanocortin neurons promotes obesity via the hypothalamus‐adipose axis, The FASEB Journal, 2021, 35(3): e21408（IF=5.834, JCR Q1）
